Although the consensus on PD-L1 positivity is lacking in NEN, CPS 1 is considered a cutoff value for ICI treatment in gastric cancers, cervical cancers, and head and neck squamous cell carcinomas [42,43,44]. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.